Live attenuated influenza vaccine (investigational, H2N3)

live attenuated influenza vaccine (H2N3), investigational · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Live attenuated influenza vaccine (investigational, H2N3), covering 2013-02-11 to 2013-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Immunogenicity of a Live Attenuated Virus Vaccine for the Prevention of H2N3 Influenza [Phase 1]

See pricing